Liang Chu

The Second Affiliated Hospital of Bengbu Medical College — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

30h-index2.9kcitations79works12.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(18), Virus-based gene therapy research(16), Cancer-related molecular mechanisms research(14), Cancer Research and Treatments(9), MicroRNA in disease regulation(8)

Publications78 total

METTL3-mediated m6A methylation on lncRNA H19 inhibits intrahepatic cholangiocarcinoma progression through PPARγ downregulation
International Journal of Biological Sciences·2025Open Access
Development of a cancer-specific survival assessment for lymph node-positive colorectal cancer patients treated with adjuvant chemotherapy
Frontiers in Surgery·2025Open Access
Stabilizing black-phase FAPbI3 films for effective photovoltaic devices
Science Bulletin·2025
Insight into the structure, function and the tumor suppression effect of gasdermin E
Biochemical Pharmacology·2024· 6 cited
YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD‐L1/VEGFA Axis
Advanced Science·2024· 55 citedOpen Access
Liquid–liquid phase separation in Alzheimer’s disease
Journal of Molecular Medicine·2024· 27 cited
Potential auto-driving threat: Universal rain-removal attack
iScience·2023· 6 citedOpen Access
CENPA facilitates hepatocellular carcinoma proliferation by cooperating with YY1 to drive transcription of CCND1 and NRP2.
Research Square (Research Square)·2023Open Access
m6A Modification—Association with Oxidative Stress and Implications on Eye Diseases
Antioxidants·2023· 20 citedOpen Access
PEDOT:PSS materials for optoelectronics, thermoelectrics, and flexible and stretchable electronics
Journal of Materials Chemistry A·2023· 121 citedOpen Access
Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling
Cellular & Molecular Biology Letters·2022· 14 citedOpen Access
Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application
Frontiers in Oncology·2022· 24 citedOpen Access
The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
Experimental Hematology and Oncology·2022· 23 citedOpen Access
Insight into the structure, physiological function, and role in cancer of m6A readers—YTH domain-containing proteins
Cell Death Discovery·2022· 81 citedOpen Access
Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation
Cell Death and Differentiation·2022· 65 citedOpen Access
18β-Glycyrrhetinic Acid Inhibits TGF-β-Induced Epithelial-to-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma by Targeting STAT3
The American Journal of Chinese Medicine·2021· 15 cited
Current status of traditional Chinese medicine for the treatment of COVID-19 in China
Chinese Medicine·2021· 41 citedOpen Access
SnoRD126 promotes the proliferation of hepatocellular carcinoma cells through transcriptional regulation of FGFR2 activation in combination with hnRNPK
Aging·2021· 15 citedOpen Access
miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4
Frontiers in Oncology·2021· 25 citedOpen Access
H19 Promotes HCC Bone Metastasis Through Reducing Osteoprotegerin Expression in a Protein Phosphatase 1 Catalytic Subunit Alpha/p38 Mitogen‐Activated Protein Kinase–Dependent Manner and Sponging microRNA 200b‐3p
Hepatology·2020· 93 cited
page 1 of 4Next →

Frequent Co-authors

Bixiang Zhang(18), Huifang Liang(14), Xinyuan Liu(11), Xiaoping Chen(9), Qiumeng Liu(9), Junnan Liang(8), Jingyuan Wen(7), Jin Chen(7), Zhao Huang(6), Sujing Yuan(6), Jingyu Liao(6), Haineng Xu(6), Yigang Wang(6), Yu Wu(5), Zeyang Ding(5), Zhanguo Zhang(5), Zhibin Liao(5), Zhaoqi Zhang(4), Xian-Long Fang(4), Shuai Wu(4)